ICD-10 title: Pulmonary blastomycosis
ICD-10 B43.2 is a billable code used to indicate a diagnosis of icd-10 title: pulmonary blastomycosis.
Pulmonary blastomycosis is a fungal infection caused by the organism Blastomyces dermatitidis, primarily affecting the lungs. This condition is endemic in certain regions, particularly in the Midwest and Southeastern United States, where the fungus thrives in moist soil and decaying organic matter. Patients may present with a range of respiratory symptoms, including cough, chest pain, fever, and difficulty breathing. The infection can be acute or chronic and may mimic other pulmonary conditions such as tuberculosis or lung cancer. Diagnosis is typically confirmed through culture, serology, or histopathological examination of tissue samples. Immunocompromised individuals, such as those with HIV/AIDS, cancer, or those on immunosuppressive therapy, are at a higher risk for severe manifestations of the disease. Treatment usually involves antifungal medications, with itraconazole and amphotericin B being the most commonly used agents. Early diagnosis and appropriate treatment are crucial to prevent complications, including dissemination of the infection to other organs.
Detailed clinical notes on symptoms, diagnostic tests, and treatment plans.
Patients presenting with respiratory symptoms and a history of exposure to endemic areas.
Ensure documentation includes immunocompromised status and response to treatment.
Comprehensive pulmonary function tests and imaging studies.
Patients with chronic cough and abnormal chest imaging.
Document differential diagnoses to support coding.
Used to confirm diagnosis of pulmonary blastomycosis.
Document the type of culture performed and results.
Infectious disease specialists should ensure accurate reporting of culture results.
Common symptoms include cough, chest pain, fever, and difficulty breathing. Some patients may also experience weight loss and night sweats.
Diagnosis is typically made through culture, serological tests, or histopathological examination of tissue samples.
Treatment usually involves antifungal medications such as itraconazole or amphotericin B, depending on the severity of the infection.
